- Global Pharma News & Resources

Key Takeaways from FMI’s Covid-19 Diagnostics Market Study

A recent market study published by Future Market Insights (FMI) on the Covid-19 Diagnostics Market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the market, growth prospects of the market are obtained with utmost precision.

The report features unique and salient factors that may make a huge impact on the development of the Covid-19 Diagnostics Market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the market in the years to come. The report provides detailed information about the current and future growth prospects of the market in the most comprehensive way for better understanding of readers.

Key Segments of Covid-19 Diagnostics Market

FMI’s study on the market offers information divided into four important segments— Drug Class, Route of Administration, Application, and Region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

To remain ‘ahead’ of your competitors, request for a sample>>>

Product Type·         Instruments·         Test Kits·         Reagents and Consumables
Sample Type·         Oropharyngeal & Nasopharyngeal Swabs·         Blood·         Urine·         Others
Technology·         PCR·         ELISA·         POC
Region·         North America·         Latin America·         Europe·         East Asia·         South Asia·         Oceania·         Middle East and Africa

For any Queries Linked with the Report, Ask an Analyst@

Key Takeaways from FMI’s Covid-19 Diagnostics Market Study

  • Molecular assay holds the largest share right now and the trend is expected to continue till the end of 2020. This could be attributed to the fact that molecular assays have been looked upon as a gold standard to detect novel viral infections
  • Diagnostic labs contributed to more than 60% of total market share in 2020’s first quarter

The number of Covid-infected patients have been increasing at an alarming rate every single day. This is bound to drive the Covid-19 diagnostics market exponentially – says the FMI analyst.

Key Challenges for Market Players & Researchers

Right now, the challenges faced include lack of information regarding the virus, like genetic information, biologics, duration of immunity in the recovered patients.

Certain treatment options that are expected to be potential game changers include ACE-Mab by Sorrento Therapeutics, HCQ (Hydroxychloroquine and chloroquine), Remdesivir antiviral by Gilead Sciences, and Canakinumab (Ilaris) by Novartis.

Moreover, options like cell-based therapies that involve natural killer cells or Mesenchymal stem cells and plasma therapies are on the verge of providing personalized treatment options.

Key Participant Insights

The key participants are focusing on acceleration of production as well as new product approval phase. For example – Novacyt Group, in Mar 2020, received EUA for 2-hour Covid-19 test. Also, in Apr 2020, CE approval was received by Abbott for IgG serology blood test for Covid-19.

The other players in the market include Veredus Laboratories, Thermo Fisher Scientific, Inc., Quidel Corporation, Perkin Elmer, Inc., Neuberg Diagnostics, Mylab Discovery Solutions Pvt Ltd., Luminex Corporation, Laboratory Corporation of America Holdings, Hologic Inc., Danaher, Cepheid, bioMérieux SA, Altona Diagnostics GmbH, ALDATU BIOSCIENCES, ADT Biotech Sdn Bhd, and 1drop Inc.

Contact Sales for Further Assistance in Purchasing this Report@

More from FMI’s Healthcare, Pharmaceuticals and Medical devices Market Intelligence:

  • Oral Antiseptics Market Segmented by (Product Type – Cetylpyridinium Chloride Based, Chlorhexidine Gluconate Based, Herbal & Essential Oils; Distribution Channel – Supermarket/Hypermarket, Drug Store, Retail Pharmacy & E-commerce)
  • Dental Lasers Market Segmentation by Laser Type (Dental Surgical Lasers, Dental Welding Lasers); By End Users (Dental Clinics, Hospitals, Ambulatory Surgical Centers)
  • Seasonal Affective Disorder Therapeutics Market Segmentation by Treatment Type (Drugs, Devices); By Disorder Type (Unipolar Disorder, Bipolar Disorder); by Distribution Channel (Institutional Sales, Retail Sales)

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Editor Details

Last Updated: 05-Apr-2021